Melasma Treatment with Acroma-QS® in FST V

 Dr. Fabíola Picosse,

Dermatologist, UNIFESP,

São Paulo, Brazil

Dr. Fabíola Picosse used the ETHEREA-MX® platform with the Acroma-QS® handpiece.

Treatment:

Melasma is a common clinical condition characterized by skin hyperpigmentation, with a preference for areas exposed to the sun, such as the face, especially on the cheeks, forehead, upper lip, and chin. Its etiology is multifactorial, involving hormonal factors, sun exposure, and genetic predisposition.

The treatment of melasma can be challenging. The combination of topical and oral therapies and procedures such as the use of Q-Switched (ns) and Picosecond (ps) lasers has proven to be effective.

Short-pulse lasers (ns and ps) promote the breakdown of pigment through a photoacoustic effect, without generating heat. The Nd:YAG 1,064 nm wavelength is indicated for darker and deeper pigmentations, allowing a more complete

and safer treatment approach for melasma, even in higher phototypes.

The Acroma-QS® handpiece is compatible with the ETHEREA-MX® and ZYE® platforms, has a fixed pulse time of 20ns, different spot sizes at two wavelengths, Nd:YAG 1,064 nm and KTP 532 nm. Acroma-QS ® also offers the LASER TONING rejuvenation mode, which restores vigor and vitality to the skin—with maximum safety, no downtime and no phototype restrictions.

In the case below, Dr. Fabíola Picosse performed 4 sessions using the LASER TONING mode of the Acroma-QS®, combined with the use of tranexamic acid VO, which was administered for only 3 months throughout the entire treatment. The treatments were performed every 3 months.

See the result:

Before and after 1 year

.